Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Maciej M. Mrugała, David Tran et al.|The Lancet Oncology|2017

Cited by 1.1k